GlassScriptPhysician profile
Mudasiru A Carew
NPI 1487610044
$3,791.36
in general payments reported to CMS, 2019-2025
38 companies · $682 in 2025
The $682 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $452 · 2021: $539 · 2022: $622 · 2023: $462 · 2024: $260 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $465.51 | 2022-2024 | Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $400.42 | 2019-2023 | Amplatzer Amulet |
| Boston Scientific Corporation | $310.99 | 2022-2025 | Watchman |
| Pfizer INC. | $289.70 | 2019-2025 | |
| Allergan, INC. | $226.96 | 2019-2020 | |
| Lilly USA, LLC | $208.87 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $202.00 | 2019-2025 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.65 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $173.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $169.17 | 2020-2025 | Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.07 | 2019-2023 | Xifaxan |
| Exact Sciences Corporation | $99.58 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $82.90 | 2019-2025 | Otezla, Repatha, Repatha |
| Avanir Pharmaceuticals, INC. | $71.96 | 2021 | |
| Hologic Sales and Service, LLC | $70.59 | 2025 | Aptima |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mudasiru Carew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.